Literature DB >> 11368112

Epidemiology of postshigellosis persistent diarrhea in young children.

F Ahmed1, M Ansaruzzaman, E Haque, M R Rao, J D Clemens.   

Abstract

BACKGROUND: Dysentery accounts for 20% of the 4.6 million diarrhea-associated deaths among children in developing countries, with the risk from death in dysenteric persistent diarrhea 10-fold higher than that in acute dysentery. Although Shigella accounts for the majority of dysenteric episodes, very little is known about the epidemiology of postshigellosis persistent diarrhea.
METHODS: Rural Bangladeshi children younger than 5 years of age (n = 1,756) were followed for 1 month after exposure to sentinel cases of Shigella dysentery. The likelihood of an acute diarrheal episode becoming persistent was assessed.
RESULTS: Diarrhea caused by Shigella was significantly associated with an increased risk of persistent diarrhea (age-adjusted relative risk, 1.83; 95% confidence interval, 1.19 to 2.81). Despite the use of nalidixic acid in dysenteric episodes, persistent diarrhea occurred in 23% of children with shigellosis. Infection by multiply antibiotic-resistant Shigella isolates (age-adjusted relative risk, 3.76; 95% confidence interval, 1.51 to 9.36) and occurrence of shigellosis during infancy were observed to be risk factors for initiation of Shigella diarrhea persistence. However, 88% of the persistent shigellosis episodes occurred in older children, 50% were associated with nondysenteric shigellosis and 79% were caused by Shigella species other than Shigella dysenteriae 1.
CONCLUSIONS: These data demonstrate the importance of Shigella as a cause of persistent diarrhea and indicate that strategies to prevent postshigellosis persistent diarrhea must be broad-based, with a focus on older children as well as infants, management of nondysenteric as well as dysenteric disease and prevention of diarrhea caused by multiple Shigella species.

Entities:  

Mesh:

Year:  2001        PMID: 11368112     DOI: 10.1097/00006454-200105000-00011

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  9 in total

1.  Immunoproteomics of membrane proteins of Shigella flexneri 2a 2457T.

Authors:  Tian-Yi Ying; Jun-Jun Wang; Heng-Liang Wang; Er-Ling Feng; Kai-Hua Wei; Liu-Yu Huang; Pei-Tang Huang; Cui-Fen Huang
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

2.  Failure of Syndrome-Based Diarrhea Management Guidelines to Detect Shigella Infections in Kenyan Children.

Authors:  P B Pavlinac; D M Denno; G C John-Stewart; F M Onchiri; J M Naulikha; E A Odundo; C E Hulseberg; B O Singa; L E Manhart; J L Walson
Journal:  J Pediatric Infect Dis Soc       Date:  2015-07-12       Impact factor: 3.164

Review 3.  Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005.

Authors:  P K Ram; J A Crump; S K Gupta; M A Miller; E D Mintz
Journal:  Epidemiol Infect       Date:  2007-08-09       Impact factor: 2.451

4.  The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study.

Authors:  Karen L Kotloff; William C Blackwelder; Dilruba Nasrin; James P Nataro; Tamer H Farag; Annemieke van Eijk; Richard A Adegbola; Pedro L Alonso; Robert F Breiman; Abu Syed Golam Faruque; Debasish Saha; Samba O Sow; Dipika Sur; Anita K M Zaidi; Kousick Biswas; Sandra Panchalingam; John D Clemens; Dani Cohen; Roger I Glass; Eric D Mintz; Halvor Sommerfelt; Myron M Levine
Journal:  Clin Infect Dis       Date:  2012-12       Impact factor: 9.079

Review 5.  Management of children with prolonged diarrhea.

Authors:  Antonietta Giannattasio; Alfredo Guarino; Andrea Lo Vecchio
Journal:  F1000Res       Date:  2016-02-23

6.  Microevolution and Patterns of Transmission of Shigella sonnei within Cyclic Outbreaks Shigellosis, Israel.

Authors:  Adi Behar; Kate Susan Baker; Ravit Bassal; Analia Ezernitchi; Lea Valinsky; Nicholas R Thomson; Daniel Cohen
Journal:  Emerg Infect Dis       Date:  2018-07       Impact factor: 6.883

7.  Could a Shigella vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021.

Authors:  Karoun H Bagamian; Chloe Puett; John D Anderson; Farzana Muhib; Clint Pecenka; Jere Behrman; Robert F Breiman; Ijeoma Edoka; Susan Horton; Gagandeep Kang; Karen L Kotloff; Claudio F Lanata; James A Platts-Mills; Firdausi Qadri; Elizabeth T Rogawski McQuade; Christopher Sudfeld; Pascale Vonaesch; Thomas F Wierzba; Suzanne Scheele
Journal:  Vaccine X       Date:  2022-09-21

8.  Recent trends in the epidemiology of shigellosis in Israel.

Authors:  D Cohen; R Bassal; S Goren; T Rouach; D Taran; B Schemberg; N Peled; Y Keness; S Ken-Dror; V Vasilev; I Nissan; V Agmon; T Shohat
Journal:  Epidemiol Infect       Date:  2014-02-20       Impact factor: 4.434

9.  A High Burden of Asymptomatic Gastrointestinal Infections in Traditional Communities in Papua New Guinea.

Authors:  Paul F Horwood; Kevin W Soli; Tobias Maure; Yuichi I Naito; Ayako Morita; Kazumi Natsuhara; Kiyoshi Tadokoro; Jun Baba; Shingo Odani; Eriko Tomitsuka; Katsura Igai; Jo-Ann Larkins; Peter M Siba; William Pomat; Emma S McBryde; Masahiro Umezaki; Andrew R Greenhill
Journal:  Am J Trop Med Hyg       Date:  2017-09-21       Impact factor: 2.345

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.